Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
PMID:35013352
This quality assurance approach supports the advancement of research by controlling and documenting experimental variables related to compound quality
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized Phase 2a trial
The amino acid sequence is the same compound that Eli Lilly has published, but the research-grade material supplied here is not equivalent to Eli Lilly's investigational drug product, is not produced under the same regulatory framework, and is not a substitute for any clinical trial supply, compounded preparation, or future approved formulation
No published human trials
US$ 22.56
US$ 22.89
US$ 28.20
US$ 21.33
US$ 26.00
US$ 23.86
US$ 21.61
US$ 27.52
US$ 22.55
